Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The role of GLP-1 receptor agonists in opioid addiction is still under investigation, but initial studies suggest that these drugs could reduce the rewarding effects of opioids, making them less appealing to users
Tap an ingredient for the detail: Sensoril Ashwagandha ExtractCns Depressants Moderate Interaction Summary Theoretically, taking ashwagandha might increase the sedative effects of CNS depressants
PMC 10329868
These effects are generally mild to moderate in severity, but they can lead to treatment discontinuation in approximately 4-7% of patients
How the GLP-1 Supply Tracker works Reporting: Anyone can enter the drug, dose, and pharmacy where they found stock of a GLP-1 drug or enter the same information about a pharmacy's shortage
Combines GLP-1 and GIP activity for appetite suppression, blood-sugar regulation, and improved cardiometabolic measures
